Related Experiment Video
Updated: Jan 7, 2026
Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure
Published on: June 10, 2025
De Novo Acute Heart Failure Versus Acute Decompensated Chronic Heart Failure: Are There Differences in In-Hospital
Juan David Pelaez-Martinez1, Daniel Castillo1, Jackelin Mainguez1
1Facultad de Ciencias de la Salud, Universidad Icesi, Cali 760008, Colombia.
Insights
Patients with de novo acute heart failure (dn-AHF) face higher in-hospital complications and mortality than those with acute decompensated chronic heart failure (ad-CHF). Early identification and phenotype-specific management are crucial for improving outcomes in dn-AHF.
Area of Science:
- Cardiology
- Internal Medicine
- Clinical Research
Background:
- Heart failure (HF) significantly contributes to global morbidity and mortality.
- Distinguishing between acute decompensated chronic HF (ad-CHF) and de novo acute HF (dn-AHF) is crucial, as they present differently.
- Limited comparative data exists on in-hospital outcomes for dn-AHF versus ad-CHF in Latin America.
Purpose of the Study:
- To compare in-hospital complications and mortality between patients hospitalized with dn-AHF and ad-CHF.
- To identify factors associated with increased mortality in acute HF patients.
- To provide data relevant to the Latin American population.
Main Methods:
- An ambispective study included 780 patients hospitalized for acute HF at a tertiary hospital in Colombia.
- Patients were categorized into dn-AHF or ad-CHF groups.
- Sociodemographic, clinical data, and in-hospital outcomes were compared using bivariate analysis, with Firth penalized logistic regression for mortality analysis.
Main Results:
- The study included 39.2% dn-AHF and 60.8% ad-CHF patients.
- dn-AHF patients exhibited higher rates of invasive mechanical ventilation and infections.
- In-hospital mortality was significantly higher in dn-AHF (9.8%) compared to ad-CHF (5.5%), with dn-AHF independently associated with increased mortality (OR: 1.87).
Conclusions:
- Patients with dn-AHF experienced more complications and higher mortality than ad-CHF patients, despite similar ICU admission rates.
- dn-AHF is an independent predictor of in-hospital mortality.
- Early identification, vigilant monitoring, and phenotype-specific management are essential for improving outcomes in dn-AHF, especially in those with reduced ejection fraction.
Background:
Heart failure (HF) is a major cause of global morbidity and mortality. Patients with acute decompensated chronic HF (ad-CHF) usually have more comorbidities, whereas those with de novo acute HF (dn-AHF) may have a more severe clinical presentation. Despite extensive research on HF, comparative data on in-hospital outcomes and mortality between these groups are scarce in Latin American countries. The aim of this study was to evaluate differences in in-hospital complications and mortality among patients hospitalized with either dn-AHF or ad-CHF.
Methods:
An ambispective study was conducted at a tertiary hospital in Colombia, including 780 patients hospitalized for acute HF. Patients were classified as dn-AHF or ad-CHF, and sociodemographic, clinical, and in-hospital outcomes were compared using bivariate analysis. A Firth penalized logistic regression model was used to assess the association between dn-AHF and in-hospital mortality.
Results:
Of these patients, 39.2% had dn-AHF, and 60.8% had ad-CHF. Median ages were 67 (interquartile range (IQR): 56 - 76) and 66 (IQR: 55 - 79) years, respectively. Both groups had a predominance of reduced left ventricular ejection fraction, with median values of 30% in ad-CHF and 34% in dn-AHF. Ad-CHF patients had more comorbidities, whereas dn-AHF patients showed higher rates of cardiac and non-cardiac complications. Intensive care unit (ICU) admission rates were similar, the need for invasive mechanical ventilation (P < 0.001) and the occurrence of infections (P = 0.049) were significantly more frequent in patients with dn-AHF. In-hospital mortality was higher in dn-AHF than ad-CHF (9.8% vs. 5.5%, P = 0.023). After adjustment, dn-AHF remained independently associated with greater in-hospital mortality (odds ratio (OR): 1.87; 95% confidence interval (CI): 1.07 - 3.31; P = 0.029).
Conclusions:
Patients with dn-AHF experienced more in-hospital complications and higher mortality than those with ad-CHF, despite similar ICU admission rates and fewer comorbidities. These results highlight the prognostic importance of dn-AHF and underscore the need for early identification, vigilant monitoring, and phenotype-specific management from admission to improve outcomes, particularly among patients with reduced ejection fraction.
More Related Videos
09:12Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
Related Concept Videos
01:30Heart Failure V: Medical Management
01:26Heart Failure III: Clinical Manifestations
01:17Pathophysiology of Heart Failure
01:27Heart Failure I: Introduction
01:26Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
01:29Heart Failure II: Pathophysiology